the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Govt eyes RM2b revenue contribution to GDP from biotech, bio-based industries by end-2024

KUALA LUMPUR: The government is aiming for revenue contribution of RM2 billion to Malaysia’s gross domestic product (GDP) from biotechnology and bio-based industries by the end of 2024.

Science, Technology and Innovation Minister Chang Lih Kang said that from January to May, biotechnology and bio-based companies in Malaysia recorded a total of RM1.5 billion in revenue with RM838 million worth of new investments.

“This signifies a high level of confidence in Malaysia’s ability to contribute to the modernisation of a high-tech economy through biotechnology,” he said at the curtain raiser for National Bioeconomy Showcase 2024 (NBiO Showcase 2024) today.

Chang said NBiO Showcase 2024 is targeting to attract RM1.32 billion in new investments and 500 job opportunities in the biotechnology industry. “We are confident that this new investment target can be achieved based on announcements that will be made during this event,” he added.

He said several important announcements will be made at the event, including achievements in one of the targets of the National Biotechnology Policy 2.0 involving local precision medicine, as well as the growth of the biosimilar field in Malaysia.

“Additionally, the exchange of 11 memorandums of understanding/cooperation will take place between biotechnology industry players and public and private entities, which are expected to enhance investment and development in the bioeconomy, strengthen the development of skilled human capital in biotechnology, and empower local bio-based products and services,” Chang said.

He added that the aim is not only to attract investment and industry collaboration but also to win the hearts of Malaysians to embrace biotechnology in their daily lives. “We want to show that biotechnology can lead Malaysia towards a high-tech economic modernisation while being accessible and beneficial to all segments of society,” he said.

The biotechnology and bio-based industry summit and exhibition – jointly organised by the Ministry of Science, Technology and Innovation and Bioeconomy Corp as the main organiser – will be held on July 17 and 18 at the World Trade Centre, Kuala Lumpur.

According to Bioeconomy Corp CEO Mohd Khairul Fidzal Abdul Razak, one of the main attractions of NBiO Showcase 2024 is the job opportunities offered in the biotechnology and bio-based industries.

“So far, nearly 17,000 job opportunities have been recorded by BioNexus Status companies, Bio-based Accelerator companies, and high-impact biotechnology companies in Malaysia,” he added.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings